Nasdaq Welcomed 171 IPOs in 2024
Nasdaq (NDAQ) demonstrated strong market leadership in 2024 with 171 IPOs raising $22.7 billion, maintaining an 81% win rate of eligible IPOs. The listings included 123 operating companies and 48 SPACs, extending Nasdaq's leadership to 44 consecutive quarters. The exchange attracted 23 company transfers representing $180 billion in market cap, including Palantir as the largest switch.
Notable achievements include maintaining 100% of eligible biotech listings and securing 87% of eligible SPAC IPOs, which raised $6.9 billion. Marquee listings included Lineage (largest IPO), Waystar (largest health-tech IPO), and ServiceTitan. Private equity and venture-capital backed companies represented 33% of IPOs, including Brightspring and Astera Labs.
Nasdaq (NDAQ) ha dimostrato una forte leadership di mercato nel 2024 con 171 IPO che hanno raccolto 22,7 miliardi di dollari, mantenendo un tasso di successo dell'81% per le IPO idonee. I listini comprendevano 123 aziende operative e 48 SPAC, estendendo la leadership di Nasdaq a 44 trimestri consecutivi. L'exchange ha attratto 23 trasferimenti aziendali che rappresentano 180 miliardi di dollari di capitalizzazione di mercato, inclusa Palantir come il più grande trasferimento.
I risultati notevoli includono il mantenimento del 100% delle IPO idonee nel settore biotech e il raggiungimento dell'87% delle IPO SPAC ammissibili, che hanno raccolto 6,9 miliardi di dollari. Le IPO di rilievo includevano Lineage (la più grande IPO), Waystar (la più grande IPO nel settore salute-tecnologia) e ServiceTitan. Le aziende supportate da capitale privato e venture capital rappresentavano il 33% delle IPO, inclusi Brightspring e Astera Labs.
Nasdaq (NDAQ) demostró un fuerte liderazgo en el mercado en 2024 con 171 OPVs que recaudaron 22,7 mil millones de dólares, manteniendo una tasa de éxito del 81% para las OPVs elegibles. Las listas incluyeron 123 empresas operativas y 48 SPAC, extendiendo el liderazgo de Nasdaq a 44 trimestres consecutivos. La bolsa atrajo 23 transferencias de empresas que representan 180 mil millones de dólares en capitalización de mercado, incluida Palantir como el mayor cambio.
Los logros notables incluyen mantener el 100% de las OPVs elegibles en biotecnología y asegurar el 87% de las OPVs de SPAC elegibles, que recaudaron 6,9 mil millones de dólares. Las OPVs destacadas incluyeron Lineage (la mayor OPV), Waystar (la mayor OPV en tecnología de la salud) y ServiceTitan. Las empresas respaldadas por capital privado y capital de riesgo representaron el 33% de las OPVs, incluidas Brightspring y Astera Labs.
나스닥(NDAQ)은 2024년에 171개의 IPO를 통해 227억 달러를 담보하면서 강력한 시장 리더십을 보여주었으며, 적격 IPO의 81%의 성공률을 유지했습니다. 상장에는 123개의 운영 기업과 48개의 SPAC이 포함되었으며, 나스닥의 리더십은 44분기 연속으로 이어졌습니다. 이 거래소는 230억 달러의 시가총액을 대표하는 23개의 기업 이전을 유치했으며, 그 중 Palantir가 가장 큰 이전 사례로 포함되었습니다.
눈에 띄는 성과로는 바이오텍 상장 기업의 100% 유지와 69억 달러를 모금한 적격 SPAC IPO의 87% 확보가 있습니다. 주요 상장에는 Lineage(최대 IPO), Waystar(최대 헬스테크 IPO), ServiceTitan이 포함되었습니다. 사모펀드 및 벤처 캐피탈 지원 기업은 IPO의 33%를 차지하였으며, Brightspring과 Astera Labs가 포함되었습니다.
Nasdaq (NDAQ) a démontré un solide leadership sur le marché en 2024 avec 171 IPO ayant levé 22,7 milliards de dollars, maintenant un taux de réussite de 81 % pour les IPO éligibles. Les introductions comprenaient 123 entreprises opérationnelles et 48 SPAC, prolongeant le leadership de Nasdaq à 44 trimestres consécutifs. La bourse a attiré 23 transferts d'entreprises représentant 180 milliards de dollars de capitalisation boursière, dont Palantir, le plus grand changement.
Les réalisations notables comprennent le maintien de 100 % des introductions éligibles en biotechnologie et la sécurisation de 87 % des IPO SPAC éligibles, qui ont levé 6,9 milliards de dollars. Les introductions de marque comprenaient Lineage (la plus grande IPO), Waystar (la plus grande IPO en santé-tech) et ServiceTitan. Les entreprises soutenues par des fonds d'investissement et du capital-risque représentaient 33 % des IPO, comprenant Brightspring et Astera Labs.
Nasdaq (NDAQ) zeigte im Jahr 2024 eine starke Marktführung mit 171 IPOs, die 22,7 Milliarden Dollar einbrachten, und erreichte eine Erfolgsquote von 81% bei den berechtigten IPOs. Die Listungen umfassten 123 operative Unternehmen und 48 SPACs, wodurch die Führung von Nasdaq auf 44 aufeinanderfolgende Quartale ausgeweitet wurde. Die Börse zog 23 Unternehmensübertragungen an, die 180 Milliarden Dollar an Marktkapitalisierung repräsentieren, darunter Palantir als der größte Wechsel.
Bemerkenswerte Erfolge sind das Halten von 100% der berechtigten Biotech-Listings und die Sicherung von 87% der berechtigten SPAC-IPOs, die 6,9 Milliarden Dollar einbrachten. Zu den renommierten Listings gehörten Lineage (größte IPO), Waystar (größte Health-Tech-IPO) und ServiceTitan. Unternehmen, die von Private Equity und Risikokapital unterstützt werden, stellten 33% der IPOs dar, darunter Brightspring und Astera Labs.
- Maintained market leadership with 171 IPOs raising $22.7 billion
- Achieved 81% win rate of Nasdaq-eligible IPOs
- Attracted 23 company transfers worth $180 billion in market cap
- Secured 100% of eligible biotech listings
- Captured 87% of eligible SPAC IPOs, raising $6.9 billion
- 33% of IPOs were PE and VC-backed companies
- None.
Insights
The impressive
The strong performance across healthcare, technology and biotech sectors, with a
The 2024 IPO data reveals significant market trends and structural shifts in public listings. The high volume of private equity and venture-capital backed companies (
The sustained leadership in SPAC combinations with a
Leading U.S. exchange by number of IPOs and proceeds raised for the sixth consecutive year
Featured the largest IPO and switch
Over 500 exchange transfers to Nasdaq since 2005
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today that in 2024, it welcomed 171 initial public offerings (IPOs), raising a total of
“We are proud to be the exchange of choice this year for the largest IPO and exchange transfer, and 2024 saw marquee listings across sectors coming to market,” said Jeff Thomas, Executive Vice President, Chief Revenue Officer, and Global Head of Listings at Nasdaq. “This year’s listings activity was at its highest volume since 2021 and there are hundreds of companies waiting in the wings. We are encouraged by the high volume of brands accessing the public markets with Nasdaq and our IPO Pulse Index forecasts listings momentum to carry through into 2025.”
A video accompanying this announcement is available at: https://vimeo.com/1039757132/3e764fef6e
2024 NASDAQ U.S. LISTINGS HIGHLIGHTS
- U.S. listings market leadership: Nasdaq welcomed 171 IPOs, raising
$22.7 billion . Marquee listings include Lineage (largest IPO), Waystar (largest health-tech IPO of the year), and the recent IPO of ServiceTitan. 2024 also saw a significant volume of private equity and venture-capital backed companies coming to market, representing33% of IPOs on Nasdaq this year and including Brightspring and Astera Labs. - Achieving switch milestones: Nasdaq featured 23 switches in 2024, totaling
$180 billion in market cap- including the largest exchange transfer on a U.S. exchange year-to-date with Palantir and the oldest-founded company to switch with Campbell’s. 509 companies have switched to Nasdaq since 2005. - Leading U.S. exchange for healthcare, technology and biotech IPOs: Nasdaq maintained its strong track record in the healthcare, technology and biotech sectors. Further,
100% of eligible biotech companies listed on Nasdaq in what was a banner year for the sector, including the listings of Ceribell, CG Oncology, and Tempus AI. - Helping companies join the public markets via SPACs: Nasdaq continued its influence in the SPAC market, welcoming
87% of all eligible SPAC IPOs, raising$6.9 billion . A total of 60 SPAC business combinations also listed in 2024, representing a91% -win rate in the U.S. - Advancing regional structure: To strengthen our market position across the region, Nasdaq welcomed Rachel Racz as SVP, Head of Listings for Texas, Southern U.S. and Latin America, this fall. The region currently supports over 493 clients across industries, representing a total of
$2.5 trillion in market cap. - Celebrating the 25th MarketSite anniversary: This fall, Nasdaq celebrated its 25th anniversary of the MarketSite in Times Square, well-recognized as a marquee venue for listings across the global capital markets. With a 10-story tower and state-of-the-art event spaces, the MarketSite is a physical embodiment of the Nasdaq exchange, signaling its commitment to supporting the companies shaping the future, and helping to re-define the “New Wall Street”.
- Recognizing Nasdaq listing anniversaries: Nasdaq celebrated the listing anniversaries of Tractor Supply Company (30 years), Alphabet, Inc (20 years), Micron Technology, Inc. (15 years), Fortinet (15 years), Walgreens Boots Alliance, Inc. (10 years), Crowdstrike Holdings, Inc. (5 years), and the first listing anniversary of Arm Holdings plc, among many others.
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.
Nasdaq Media Contact:
| Sophia Weiss (646) 483-6960 Sophia.weiss@nasdaq.com |
Cautionary Note Regarding Forward-Looking Statements:
Information set forth in this communication contains forward-looking statements that involve a number of risks and uncertainties. Nasdaq cautions readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking information. Forward-looking statements can be identified by words such “will,” “plans,” “expects,” “may,” “believe” and other words and terms of similar meaning. Such forward-looking statements include, but are not limited to, statements about the Company’s growth strategy and market expectations, products and services, ability to enhance or innovate new ways for companies to join the public markets, future listing activity, and other statements that are not historical facts. Forward-looking statements involve a number of risks, uncertainties, or other factors beyond Nasdaq’s control. These risks and uncertainties are detailed in Nasdaq’s filings with the U.S. Securities and Exchange Commission, including its annual reports on Form 10-K and quarterly reports on Form 10-Q which are available on Nasdaq’s investor relations website at ir.nasdaq.com and the SEC’s website at www.sec.gov. Nasdaq undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
-NDAQG-
FAQ
How many IPOs did Nasdaq (NDAQ) host in 2024?
What was Nasdaq's (NDAQ) market share of eligible IPOs in 2024?
How many company transfers did Nasdaq (NDAQ) receive in 2024?
What was the total value of SPAC IPOs on Nasdaq (NDAQ) in 2024?
What percentage of biotech companies chose Nasdaq (NDAQ) for their IPO in 2024?
